Gogia Atul, Agarwal P K
Department of Medicine, Sir Ganga Ram, Hospital, Rajinder Nagar, New Delhi-110 060, India.
Indian J Med Sci. 2006 Feb;60(2):72-81.
The Metabolic syndrome is a widely prevalent and multi-factorial disorder. The syndrome has been given several names, including- the metabolic syndrome, the insulin resistance syndrome, the plurimetabolic syndrome, and the deadly quartet. With the formulation of NCEP/ATP III guidelines, some uniformity and standardization has occurred in the definition of metabolic syndrome and has been very useful for epidemiological purposes. The mechanisms underlying the metabolic syndrome are not fully known; however resistance to insulin stimulated glucose uptake seems to modify biochemical responses in a way that predisposes to metabolic risk factors. The clinical relevance of the metabolic syndrome is related to its role in the development of cardiovascular disease. Management of the metabolic syndrome involves patient-education and intervention at various levels. Weight reduction is one of the main stays of treatment. In this article we comprehensively discuss this syndrome- the epidemiology, pathogenesis, clinical relevance and management. The need to do a comprehensive review of this particular syndrome has arisen in view of the ever increasing incidence of this entity. Soon, metabolic syndrome will overtake cigarette smoking as the number one risk factor for heart disease among the US population. Hardly any issue of any primary care medical journal can be opened without encountering an article on type 2 diabetes, dyslipidemia or hypertension. It is rare to see type 2 diabetes, dyslipidemia, obesity or hypertension in isolation. Insulin resistance and resulting hyperinsulinemia have been implicated in the development of glucose intolerance (and progression to type 2 diabetes), hypertriglyceridemia, hypertension, polycystic ovary syndrome, hypercoagulability and vascular inflammation, as well as the eventual development of atherosclerotic cardiovascular disease manifested as myocardial infarction, stroke and myriad end organ diseases. Conversely, treatment and consequent improvement of insulin resistance have been shown to result in better outcomes in virtually all of these conditions.
代谢综合征是一种广泛流行的多因素疾病。该综合征有多个名称,包括代谢综合征、胰岛素抵抗综合征、多代谢综合征和致命四重奏。随着美国国家胆固醇教育计划成人治疗组第三次报告(NCEP/ATP III)指南的制定,代谢综合征的定义有了一定的统一性和标准化,这对流行病学研究非常有用。代谢综合征的潜在机制尚未完全明确;然而,胰岛素刺激的葡萄糖摄取抵抗似乎以一种易引发代谢危险因素的方式改变生化反应。代谢综合征的临床相关性与其在心血管疾病发生中的作用有关。代谢综合征的管理涉及患者教育和多层面干预。减重是主要治疗手段之一。在本文中,我们全面讨论了该综合征——流行病学、发病机制、临床相关性及管理。鉴于该疾病发病率不断上升,有必要对这一特定综合征进行全面综述。很快,代谢综合征将超过吸烟,成为美国人群中心脏病的首要危险因素。几乎每一期初级保健医学杂志,随便翻开都会看到一篇关于2型糖尿病、血脂异常或高血压的文章。单独出现2型糖尿病、血脂异常、肥胖或高血压的情况很少见。胰岛素抵抗及由此导致的高胰岛素血症与葡萄糖耐量异常(并进展为2型糖尿病)、高甘油三酯血症、高血压、多囊卵巢综合征、高凝状态和血管炎症的发生有关,最终还会导致以心肌梗死、中风和众多终末器官疾病为表现的动脉粥样硬化性心血管疾病。相反,治疗并改善胰岛素抵抗已被证明在几乎所有这些情况下都能带来更好的结果。